Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human heat shock protein 70

EU orphan designation number: EU/3/13/1110
Active ingredient: Recombinant human heat shock protein 70
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: Orphazyme ApS
c/o COBIS A/S, Ole Maaløes Vej 3, 2200 København N, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Orphan designation EMA/OD/160/12 (2013)1603 of 12/03/2013
10/07/2017 Removal of orphan designation from Community Register